文献速递骨质疏松与钙磷/甲状旁腺

维生素D状态与慢性肾脏病患者全因死亡率:系统评价与剂量-反应Meta分析

Vitamin D status and all-cause mortality in patients with chronic kidney disease: A systematic review and dose-response meta-analysis.
PubMed 文献 · J Clin Endocrinol Metab · 2017-04-27

该系统评价与剂量-反应Meta分析纳入16项研究(17053例慢性肾脏病患者,7517例死亡),评估血清25(OH)D水平与全因死亡风险的关系。结果显示严重缺乏(<10 ng/ml)、轻度缺乏(10-20 ng/ml)和不足(20-30 ng/ml)对应的全因死亡汇总风险估计分别为1.63、1.22和1.12,25(OH)D每增加10 ng/ml与全因死亡风险降低21%相关(RR: 0.79, 95%CI: 0.70, 0.87)。

要点

  • 严重缺乏(<10 ng/ml)者全因死亡汇总风险估计为1.63(95%CI: 1.32, 1.94)。
  • 25(OH)D每增加10 ng/ml与全因死亡风险降低21%相关(RR: 0.79, 95%CI: 0.70, 0.87)。
  • 血清25(OH)D约25至30 ng/ml时观察到较低的全因死亡风险。

核心结论

  • 较高的血清25(OH)D水平与慢性肾脏病患者较低的全因死亡风险相关,但关于血清水平超过35 ng/mL尚无确凿证据。

研究设计与样本

  • 系统检索MedLine和EMBASE自建库至2016年11月,并检索相关文章和综述的参考文献列表。
  • 纳入报告三个或以上血清25(OH)D类别全因死亡风险估计的前瞻性或回顾性队列研究,也纳入以连续变量报告结果的研究。
  • 由两名独立研究者筛选和提取数据,分歧通过共识解决。
  • 共纳入13项前瞻性队列、2项回顾性队列和1项巢式病例对照研究,含17053例患者和7517例 incident death。

主要发现

  • 严重缺乏(<10 ng/ml)的全因死亡汇总风险估计为1.63(95%CI: 1.32, 1.94)。
  • 轻度缺乏(10-20 ng/ml)的全因死亡汇总风险估计为1.22(95%CI: 1.09, 1.35)。
  • 不足(20-30 ng/ml)的全因死亡汇总风险估计为1.12(95%CI: 1.06, 1.18)。
  • 血清25(OH)D每增加10 ng/ml与全因死亡风险降低21%相关(RR: 0.79, 95%CI: 0.70, 0.87)。
  • 血清25(OH)D约25至30 ng/ml时观察到较低的全因死亡风险;透析依赖患者中结果更明显;透析治疗是研究间异质性来源之一。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Prevalence of vitamin D deficiency is high in patients with chronic kidney disease. Less attention has been paid to measurement and correction of serum level of 25(OH)D in these patients. OBJECTIVE: We examined the association between different levels of serum 25(OH)D and risk of all-cause mortality in patients with chronic kidney disease. DATA SOURCES: Systematic search were done using MedLine and EMBASE from inception up to November 2016. Reference lists of all relevant articles and reviews also were searched. STUDY SELECTION: Prospective or retrospective cohort studies that reported risk estimates of all-cause mortality for three or more categories of serum 25(OH)D in patients with chronic kidney disease were selected. Studies that reported results as continuously also were included. Two independent investigators screened and selected the articles. Of 1281 identified studies, 13 prospective cohorts, two retrospective cohorts and one nested case-control study with 17053 patients and 7517 incident death were included. DATA EXTRACTION: Two independent authors extracted data from included studies. Any discrepancies were resolved through consensus. DATA SYNTHESIS: Reported risk estimates were combined using a random-effects model. Summary risk estimates of all-cause mortality were1.63 (95%CI: 1.32, 1.94) for severe deficiency (<10 ng/ml), 1.22 (95%CI: 1.09, 1.35) for mild deficiency (10-20 ng/ml) and 1.12 (95%CI: 1.06, 1.18) for insufficiency (20-30 ng/ml). Results were more evident in dialysis dependent patients. 10 ng/ml increment in serum 25(OH)D was associated with 21% reduction in the risk of overall mortality (RR: 0.79, 95%CI: 0.70, 0.87).Lower risk of all-cause mortality was observed at serum 25(OH)D about 25 to 30 ng/ml. Dialysis treatment was one of the sources of variation between studies. CONCLUSIONS: Higher levels of serum 25(OH) D were associated with lower risk of all-cause mortality in patients with chronic kidney disease, but concerning serum levels more than 35 ng/mL we have no conclusive evidence.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Jayedi A, Soltani S, Shab-Bidar S, et al. Vitamin D status and all-cause mortality in patients with chronic kidney disease: A systematic review and dose-response meta-analysis. J Clin Endocrinol Metab. 2017. PMID: 28453636. doi:10.1210/jc.2017-00105

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。